Comparison | Â | Studies | Overall effect | Heterogeneity | ||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | Z score | p value | padjust | I2 (%) | p value | |||
TT vs. CC+CT | Overall | 6 | 0.88 (0.70, 1.10) | 1.13 | 0.259 | 1.000 | 22 | 0.268 |
Caucasian | 4 | 0.75 (0.47, 1.19) | 1.23 | 0.219 | 1.000 | 30 | 0.232 | |
Asian | 2 | 0.92 (0.71, 1.20) | 0.59 | 0.553 | 1.000 | 40.8 | 0.194 | |
Prostate cancer | 2 | 1.26 (0.61, 2.62) | 0.63 | 0.527 | 1.000 | 0 | 0.947 | |
Breast cancer | 2 | 0.52 (0.27, 0.98) | 2.03 | 0.043 | 0.301 | 7.2 | 0.299 | |
Colorectal cancer | 1 | 1.03 (0.76, 1.41) | 0.20 | 0.845 | 1.000 | - | - | |
Lung cancer | 1 | 0.70 (0.43, 1.15) | 1.41 | 0.158 | 1.000 | - | - | |
CC vs. CT+TT | Overall | 6 | 1.03 (0.88, 1.20) | 0.32 | 0.748 | 1.000 | 56.8 | 0.041 |
Caucasian | 4 | 0.99 (0.76, 1.13) | 0.17 | 0.865 | 1.000 | 44.1 | 0.147 | |
Asian | 2 | 1.45 (0.74, 1.77) | 0.61 | 0.544 | 1.000 | 82.9 | 0.016 | |
Prostate cancer | 2 | 0.85 (0.70, 1.04) | 1.57 | 0.117 | 0.819 | 0 | 0.565 | |
Breast cancer | 2 | 1.10 (0.94, 1.30) | 1.18 | 0.236 | 1.000 | 6.9 | 0.300 | |
Colorectal cancer | 1 | 0.93 (0.76, 1.13) | 0.72 | 0.472 | 1.000 | - | - | |
Lung cancer | 1 | 1.45 (1.07, 1.97) | 2.42 | 0.016 | 0.112 | - | - | |
TT vs. CC | Overall | 6 | 0.86 (0.68, 1.09) | 1.26 | 0.209 | 1.000 | 42.3 | 0.123 |
Caucasian | 4 | 0.75 (0.47, 1.20) | 1.20 | 0.230 | 1.000 | 35.9 | 0.197 | |
Asian | 2 | 0.90 (0.68, 1.19) | 0.74 | 0.461 | 1.000 | 72.9 | 0.055 | |
Prostate cancer | 2 | 1.31 (0.63, 2.71) | 0.72 | 0.473 | 1.000 | 0 | 0.924 | |
Breast cancer | 2 | 0.52 (0.27, 0.97) | 2.06 | 0.039 | 0.273 | 13.6 | 0.282 | |
Colorectal cancer | 1 | 1.07 (0.77, 1.48) | 0.41 | 0.684 | 1.000 | - | - | |
Lung cancer | 1 | 0.58 (0.35, 0.99) | 2.01 | 0.044 | 0.308 | - | - | |
CT vs. CC | Overall | 6 | 1.00 (0.90, 1.10) | 0.09 | 0.932 | 1.000 | 42.1 | 0.125 |
Caucasian | 4 | 1.02 (0.90, 1.16) | 0.32 | 0.748 | 1.000 | 17.7 | 0.302 | |
Asian | 2 | 0.95 (0.80, 1.13) | 0.59 | 0.558 | 1.000 | 78 | 0.033 | |
Prostate cancer | 2 | 1.16 (0.95, 1.42) | 1.47 | 0.142 | 0.994 | 0 | 0.581 | |
Breast cancer | 2 | 0.94 (0.80, 1.10) | 0.78 | 0.435 | 1.000 | 0 | 0.409 | |
Colorectal cancer | 1 | 1.08 (0.87, 1.33) | 0.69 | 0.488 | 1.000 | - | - | |
Lung cancer | 1 | 0.71 (0.52, 0.98) | 2.10 | 0.036 | 0.252 | - | - | |
T vs. C | Overall | 6 | 0.97 (0.84, 1.11) | 0.49 | 0.625 | 1.000 | 60.8 | 0.026 |
Caucasian | 4 | 1.00 (0.84, 1.19) | 0.00 | 0.997 | 1.000 | 57.2 | 0.072 | |
Asian | 2 | 0.90 (0.66, 1.24) | 0.64 | 0.524 | 1.000 | 82.1 | 0.018 | |
Prostate cancer | 2 | 1.16 (0.97, 1.39) | 1.60 | 0.110 | 0.770 | 0 | 0.571 | |
Breast cancer | 2 | 0.88 (0.74, 1.06) | 1.36 | 0.173 | 1.000 | 32.1 | 0.225 | |
Colorectal cancer | 1 | 1.05 (0.90, 1.21) | 0.63 | 0.539 | 1.000 | - | - | |
Lung cancer | 1 | 0.76 (0.61, 0.95) | 2.42 | 0.016 | 0.112 | - | - |